IC-122 Treating the Endothelium: Endothelial Keratoplasty (DSAEK, DMEK, PDEK) or Not (DSO, CECs, Rho kinase)? | ASCRS
Presentation
IC-122 Treating the Endothelium: Endothelial Keratoplasty (DSAEK, DMEK, PDEK) or Not (DSO, CECs, Rho kinase)?
April 2022
Meeting: 2022 ASCRS Annual Meeting
Course Instructor: Soosan Jacob, MS, DNB, FRCS
Co-Instructors: Amar Agarwal, FRCS, Ashvin Agarwal, MD, Kathryn Colby, MD, PhD, ABO, Deepinder K. Dhaliwal, MD, Francis S. Mah, MD
This content is only available for ASCRS Members

ASCRS Membership offers access to 1,000+ educational resources on demand.

Course Description
This course will teach the attendees about the various treatment modalities for endothelial dysfunction such as - DSAEK, DMEK, PDEK, DSO, RhoKinase inhibitors etc. It will teach the surgical techniques and will talk about additional techniques to increase success rates. A perspective on DSAEK versus DMEK versus PDEK versus DSO and medical management will also be given, highlighting some challenges.

Educational Objective
Various treatment modalities available for treatment of endothelial failure

2022 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2022 ASCRS Annual Meeting in Washington, DC on April 22-25. 

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.